Latest Insider Transactions at Cytokinetics Inc (CYTK)
This section provides a real-time view of insider transactions for Cytokinetics Inc (CYTK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CYTOKINETICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CYTOKINETICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 30
2024
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,500
+2.72%
|
$69,000
$6.67 P/Share
|
|
Jul 29
2024
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
5,000
-19.53%
|
$295,000
$59.84 P/Share
|
|
Jul 29
2024
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+16.34%
|
$105,000
$21.61 P/Share
|
|
Jul 23
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
7,300
-2.74%
|
$416,100
$57.02 P/Share
|
|
Jul 23
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+3.8%
|
$37,100
$7.96 P/Share
|
|
Jul 15
2024
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
5,000
-19.53%
|
$275,000
$55.82 P/Share
|
|
Jul 15
2024
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+16.34%
|
$50,000
$10.68 P/Share
|
|
Jul 10
2024
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
11,500
-2.8%
|
$621,000
$54.29 P/Share
|
|
Jul 10
2024
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,767
+1.38%
|
$34,602
$6.67 P/Share
|
|
Jul 09
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
7,300
-2.67%
|
$401,500
$55.9 P/Share
|
|
Jul 09
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+3.69%
|
$37,100
$7.96 P/Share
|
|
Jul 05
2024
|
Robert Arthur Harrington Director |
SELL
Open market or private sale
|
Direct |
253
-1.6%
|
$13,662
$54.61 P/Share
|
|
Jul 01
2024
|
Wendall Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
114
+0.46%
|
-
|
|
Jul 01
2024
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
114
+0.5%
|
-
|
|
Jul 01
2024
|
Robert Arthur Harrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
228
+1.43%
|
-
|
|
Jul 01
2024
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
388
+1.01%
|
-
|
|
Jul 01
2024
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
228
+0.9%
|
-
|
|
Jul 01
2024
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
5,000
-19.53%
|
$270,000
$54.22 P/Share
|
|
Jul 01
2024
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+16.34%
|
$50,000
$10.68 P/Share
|
|
Jul 01
2024
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
11,500
-2.76%
|
$621,000
$54.05 P/Share
|
|
Jun 25
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
7,300
-2.66%
|
$386,900
$53.73 P/Share
|
|
Jun 25
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+3.69%
|
$37,100
$7.96 P/Share
|
|
Jun 17
2024
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
5,000
-19.53%
|
$260,000
$52.55 P/Share
|
|
Jun 17
2024
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+16.34%
|
$50,000
$10.68 P/Share
|
|
Jun 17
2024
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
22,500
-2.6%
|
$1,170,000
$52.59 P/Share
|
|
Jun 11
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
7,788
-2.76%
|
$412,764
$53.04 P/Share
|
|
Jun 11
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,422
+3.66%
|
$37,954
$7.96 P/Share
|
|
Jun 10
2024
|
Muna Bhanji Director |
SELL
Open market or private sale
|
Direct |
2,000
-10.19%
|
$104,000
$52.07 P/Share
|
|
Jun 04
2024
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
22,500
-4.87%
|
$1,080,000
$48.85 P/Share
|
|
Jun 03
2024
|
Robert Arthur Harrington Director |
SELL
Open market or private sale
|
Direct |
1,580
-9.23%
|
$75,840
$48.64 P/Share
|
|
Jun 03
2024
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
5,000
-24.27%
|
$240,000
$48.64 P/Share
|
|
Jun 03
2024
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+19.53%
|
$50,000
$10.68 P/Share
|
|
Jun 03
2024
|
Robert Wong VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
13,011
-43.86%
|
$624,528
$48.88 P/Share
|
|
May 31
2024
|
Sung Lee EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,684
+50.0%
|
-
|
|
May 15
2024
|
Muna Bhanji Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,600
+22.19%
|
-
|
|
May 15
2024
|
Robert Arthur Harrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,600
+24.65%
|
-
|
|
May 15
2024
|
Santo J Costa Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,600
+21.37%
|
-
|
|
May 15
2024
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,600
+19.75%
|
-
|
|
May 15
2024
|
Wendall Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,600
+18.71%
|
-
|
|
May 15
2024
|
B Lynne Parshall Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,600
+21.37%
|
-
|
|
May 15
2024
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,600
+18.35%
|
-
|
|
May 15
2024
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,600
+12.94%
|
-
|
|
May 07
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
15,547
-5.14%
|
$1,010,555
$65.11 P/Share
|
|
May 07
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
14,186
+8.51%
|
$85,116
$6.67 P/Share
|
|
Apr 25
2024
|
John T Henderson Director |
SELL
Open market or private sale
|
Direct |
10,562
-24.77%
|
$675,968
$64.54 P/Share
|
|
Apr 12
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Bona fide gift
|
Direct |
150
-0.11%
|
-
|
|
Apr 09
2024
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
32,605
-9.76%
|
$2,412,770
$74.31 P/Share
|
|
Apr 09
2024
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
28,605
+14.32%
|
$171,630
$6.67 P/Share
|
|
Mar 14
2024
|
Robert Wong VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,079
+12.09%
|
-
|
|
Mar 14
2024
|
Andrew Callos EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,941
+20.96%
|
-
|